<?xml version="1.0" encoding="UTF-8"?>
<p>More advanced approaches using computational drug repositioning studies are currently underway to select already available antiviral drugs such as Carfilzomib, Eravacycline, Valrubicin and more to use as COVID-19 treatments [
 <xref rid="B91-viruses-12-01058" ref-type="bibr">91</xref>]. This study describes the potential of the approved anticancer drug Carfilzomib for COVID-19 and other drugs such as antibiotics through studying protein docking sites, molecular dynamics simulations and binding free energies of approved drugs and drug candidates in clinical trials narrowing the drug search for COVID-19 [
 <xref rid="B91-viruses-12-01058" ref-type="bibr">91</xref>]. 
</p>
